Newsroom

Sorted by: Latest

-

AFYREN Announces Its Financial Calendar for Fiscal Year 2026

CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a circular model, announces today its financial calendar for 2026. Indicative financial calendar1 Events Dates 2025 Full-Year Results Tuesday March 31, 2026 (after market close) Annual General Meeting Tuesday June 16, 2026 2026 Half-Year Results Friday September 25, 2026 (bef...
-

SEMCO Technologies Announces Its 2026 Financial Calendar

CASTRIES, France--(BUSINESS WIRE)--Regulatory News: SEMCO Technologies (ISIN: FR0014010H01; Ticker: ALSEM), a company specializing in the design and manufacture of strategic components for the production of semiconductors, today announces its 2026 financial calendar. Events Dates* 2025 annual revenue January 28, 2026 2025 annual results April 13, 2026 Annual General Meeting June 29, 2026 First half 2026 revenue July 28, 2026 First half 2026 results September 22, 2026 Note (*): All publications...
-

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Integer Holdings Corporation (ITGR) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) common stock between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). Integer investors have until February 9, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LO...
-

ADOCIA annonce son calendrier financier pour l’année 2026

LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques innovantes pour le traitement du diabète et de l’obésité, annonce aujourd'hui son calendrier financier pour l’année 2026. 24 février 2026 Publication du chiffre d’affaires du 4ème trimestre 2025 21 avril 2026 Publication des résultats annuels 2025 12 mai 2026 Publication du chiffre...
-

AFYREN annonce son calendrier financier pour l’exercice 2026

CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), société de greentech qui offre aux industriels des produits biosourcés et bas-carbone grâce à sa technologie de fermentation unique basée sur un modèle complètement circulaire, annonce aujourd'hui son calendrier financier pour l’exercice 2026. Calendrier indicatif1 Évènements Dates Résultats annuels 2025 Mardi 31 mars 2026 (après bourse) Assemblée Générale annuelle Mardi 16 juin 2026 Résultats semes...
-

ADOCIA Announces its Financial Calendar for 2026

LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, today announced its financial calendar for 2026. February 24, 2026   Publication of revenue for Q4 2025 April 21, 2026   Publication of 2025 financial statements May 12, 2026   Publication of revenue for Q1 2026 June 3, 2026   Annual sharehold...
-

Katalist Raises $1.5M to Build the Next Generation Video Production Operating System

SAN FRANCISCO--(BUSINESS WIRE)--Katalist Raises $1.5M to Build the Next Generation Video Production Operating System...
-

HHR: Candlelight Vigil to Mark National Homeless Persons' Memorial Day

LOS ANGELES--(BUSINESS WIRE)--Candlelight Vigil to Mark National Homeless Persons' Memorial Day. - Sun., Dec. 21st...
-

Medincell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): Place de cotation : Euronext Paris, Compartiment B Code ISIN : FR0004065605 Date Nombre de titres composant le capital en circulation Nombre total de droits de vote Total brut (1) Total net (2) 30 novembre 2025 33 125 992 43 655 841 43 645 841 (1) Le nombre de droits de vote bruts (ou droits de vote “théoriques”) sert de base de calcul pour les franchissements de seuil. Conformément à l’article 223-11 du Règlement G...
-

New Research From Relyance AI Finds Data Transparency in AI Now Rivals Price as a Driver of Holiday Purchasing Behavior and Brand Loyalty

SAN FRANCISCO--(BUSINESS WIRE)--Relyance AI, the first AI-native data security platform that tracks dynamic data flows in real-time from source code to AI models, today released an AI Data Ultimatum public opinion survey of 1,017 U.S. consumers to quantify how holiday shopping behavior is impacted by brand management of personal data in AI systems. Findings reveal that Americans are entering the holidays stressed, skeptical, and more digitally exposed than ever – conditions that dramatically ra...